Certainly. Thank you for inviting me to speak.
The previous Public Petitions Committee did a huge amount of work on the petition and seemed to understand the issues very well. I offer apologies for the fact that Lorraine Cleaver cannot be here this morning; I think that she has come to Parliament on most occasions on which the petition has been considered.
I do not want to go over all the issues again. It is a big women’s issue, in that it predominantly affects women. It is also cross-cutting, in that it is not just a health issue. The fact that someone with the condition might not be able to work means that it gives rise to economic and care issues. It is hugely significant that it affects mainly women.
There is a problem with diagnosis and treatment. Sometimes patients are just parked on T4, which is synthetic thyroxine. Although many members of the medical profession will say that people do well on that, many people who are on it—as I was for many years—do not know that they are not doing well, because they are managing to function. They do not realise that things that they have such as fibromyalgia, difficulty getting up in the morning, thinning hair and dry skin are an indication that they are not doing that well on their T4. For a lot of patients on T3, like me, it makes a huge difference, because they might not convert T4 so well.
Another issue is whether desiccated thyroid hormone should be available. It is available in other countries, and a lot of patients in this country use the internet to get it, but they sometimes have problems with the cloning of cards and suchlike. Buying it from abroad is tempting, but personally I would not want to do that. GPs could prescribe it here, but they are concerned that there might be backlash repercussions. The availability of desiccated thyroid hormone is an important issue.
To cut to the chase, I refer to the choice of actions that the committee has in its paper on the petition. Given that the Public Petitions Committee has done a lot work on the petition—I think that you have about 100 stories, which we got together really quickly, that tell the tale—it would be a shame if the committee closed the petition or even referred it to the Health and Sport Committee. I am not saying that that is not an option, but I think that the petition is a bit more cross-cutting, particularly given the equality issues for women that are involved.
With regard to the possible actions in the committee’s paper, the Scottish Government could try to extrapolate Scottish figures from the survey, although I do not think that the experience here will be particularly different from that in the rest of the UK. I know that the petitioner would like the committee to take evidence, if possible, from Dr John Midgley, who has a lot of good knowledge and experience to share and is willing to speak to the committee. The previous committee was thinking about that, and it is something that I would recommend.
For me, it would be ideal if the committee did its own inquiry or mini inquiry into the issue, although I do not know what the committee’s workload or timescales are. However, the committee has taken a huge interest in the petition for such a long time and I think that the petitioner would think that an inquiry is worth doing. The thyroid issue also takes in other issues, such as fibromyalgia and myalgic encephalopathy. For example, figures show that quite a high proportion of people with ME have an underactive thyroid. So, the thyroid condition could be having an undiagnosed impact on other conditions.
I make a plea to the committee to build on the work that has been done over the past five years and see whether it can come to any conclusions or produce any outcomes.